PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Pharmacist-Led Penicillin Allergy Delabeling: Promising but Largely Pre-Post Evidence

★ Editor's Pickpenicillin allergydelabelingpharmacist-led interventionantimicrobial stewardshipbeta-lactampenicillin skin testingdirect oral challengecefazolinPEN-FASTscoping reviewclinical pharmacy practice Clinical Pharmacy Practice

Background Information

Pharmacists lead the charge in correcting penicillin allergy mislabels, boosting stewardship.

Penicillin allergy mislabeling can lead to inappropriate antibiotic use and increased resistance risk. Pharmacist-led interventions improved beta-lactam prescribing and decreased broad-spectrum antibiotic use, reducing hospital stays and costs. Pharmacist involvement in allergy evaluations can optimize antibiotic selection and enhance stewardship but requires validation across settings. Pharmacist-led penicillin allergy assessments can improve antimicrobial use and stewardship.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Mandacı C, Kara E, Metan G

Citation: Mandacı C, Kara E, Metan G Pharmacist-led penicillin allergy interventions and delabeling outcomes: a scoping review. Antimicrobial stewardship & healthcare epidemiology : ASHE. 2026;6(1):e293. doi:10.1017/ash.2026.10831

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.